Annual report pursuant to Section 13 and 15(d)

ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)

v3.22.1
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Nov. 16, 2021
USD ($)
$ / shares
shares
Mar. 31, 2021
Dec. 31, 2021
USD ($)
item
$ / shares
Jan. 31, 2022
USD ($)
Dec. 31, 2020
USD ($)
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS          
Number of branded drugs in product portfolio | item     5    
Number of authorized generic prescription drugs | item     3    
Cash and cash equivalents | $     $ 49,081   $ 8,246
IPO          
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS          
Proceeds of initial public offering | $ $ 30,600        
Price per share | $ / shares $ 10.00        
Cumulative Convertible Class A Preferred Stock          
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS          
Preferred stock dividend rate   8.00%      
Number of shared issued for conversion of preferred stock | shares 2,231,346        
Price per share | $ / shares     $ 25.00    
Cumulative Convertible Class A Preferred Stock | Fortress Note          
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS          
Number of shares issued for conversion of related part debt | shares 1,610,467        
Cumulative Convertible Class A Preferred Stock | IPO | Fortress Note          
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS          
Price per share | $ / shares $ 10.00        
Term Loan | Subsequent Event          
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS          
LineOfCredit | $       $ 15,000